Search - tctmd.com

Displaying 581 - 600 of 2772

Sort: Relevancy | Date

Presentation THT Abstracts 2025

VenstraMedical: The Smallest Full Flow pVAD

February 11, 2025

Presentation THT Abstracts 2025

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Presenter: Jason Feinman

February 11, 2025

Presentation THT Abstracts 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation THT Abstracts 2025

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation THT Abstracts 2025

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT Abstracts 2025

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Disparities in MDD Incidence Between HFpEF and HFrEF Patients

Presenter: Ibrahim Kamel

February 11, 2025

Presentation THT Abstracts 2025

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Presenter: Emmanuel Otabor

February 11, 2025

Presentation THT 2025

Position 1: It Should be Class IIa

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

Position 2: It Should be Class I

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

The Best Thing Since Sliced Bread.

Presenter: William Abraham

February 11, 2025

Presentation THT 2025

A Strategy That Has Created More Confusion Than Clarity.

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Presenter: Sandip Zalawadiya

February 11, 2025

Presentation THT 2025

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Presenter: James Udelson

February 11, 2025

Advertisement

VenstraMedical: The Smallest Full Flow pVAD

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Gender Disparities in the Association of Low Dietary Protein Intake With Congestive Heart Failure: An Analysis of the NHANES Database 2017-2020

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Disparities in MDD Incidence Between HFpEF and HFrEF Patients

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Position 1: It Should be Class IIa

Position 2: It Should be Class I

The Best Thing Since Sliced Bread.

A Strategy That Has Created More Confusion Than Clarity.

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content